Bill Summary – FastDemocracy

                                                                APPROVED                 CHAPTER
                                                                APRIL 22, 2025                37
                                                               BY GOVERNOR              PUBLIC LAW
                                  STATE OF MAINE
                                          _____
                          IN THE YEAR OF OUR LORD
                        TWO THOUSAND TWENTY-FIVE
                                          _____
                                  H.P. 495 - L.D. 765
       An Act to Amend the Laws Governing the Controlled Substances
                     Prescription Monitoring Program
Be it enacted by the People of the State of Maine as follows:
    Sec. 1. 22 MRSA §7246, sub-§5, as amended by PL 2017, c. 360, §2, is further
amended to read:
    5. Prescriber. "Prescriber" means a licensed health care professional or veterinarian
with prescriptive authority, including a licensed health care professional or veterinarian
who uses telehealth in providing health care to prescribe controlled substances to patients
located in this State.
    Sec. 2. 22 MRSA §7246, sub-§8 is enacted to read:
    8. Telehealth. "Telehealth" has the same meaning as in Title 24-A, section 4316,
subsection 1, paragraph C.
    Sec. 3. 22 MRSA §7249, sub-§1, as amended by PL 2017, c. 360, §3, is further
amended to read:
    1. Information required. Except as provided in subsection 1‑A or 1‑B, each
dispenser shall submit to the department, by electronic means or other format specified in
a waiver granted by the department, specific items of information regarding dispensed
controlled substances as determined by the department from the following list: through
rules adopted to implement this subsection.
    A. The dispenser identification number;
    B. The date the prescription was filled;
    C. The prescription number;
    D. Whether the prescription is new or is a refill;
    E. The National Drug Code (NDC) for the drug dispensed;
    F. The quantity dispensed;
    G. The dosage;
                                   Page 1 - 132LR0268(02)
    H. The patient identification number;
    I. The patient name;
    J. The patient address;
    K. The patient date of birth;
    L. The prescriber identification number;
    M. The date the prescription was issued by the prescriber; and
    N. The department-issued serial number if the department chooses to establish a serial
    prescription system.
    Sec. 4. 22 MRSA §7250, sub-§8, as enacted by PL 2017, c. 460, Pt. F, §6, is
amended to read:
    8. Report regarding program. The department shall provide to the joint standing
committee of the Legislature having jurisdiction over health and human services matters
on or before January April 15th of each year, and at such other times as the committee
requests, data pertaining to the aggregate number of prescriptions of each drug required to
be included in the program, the number of prescribers participating in the program
categorized by specialty, any historical trends or patterns in prescribing practices within
the State, any progress in the implementation of information sharing agreements authorized
by subsection 4‑A and any other information pertaining to the work of the program as
requested by the committee that is reasonably available to the department, as long as all
information reasonably likely to reveal the patient or the prescriber or other person who is
the subject of the information has been removed.
    Sec. 5. 22 MRSA §7254, as amended by PL 2017, c. 213, §11, is repealed.
    Sec. 6. 32 MRSA §2210, sub-§2, ¶A, as enacted by PL 2015, c. 488, §13, is
amended by amending subparagraph (5) to read:
        (5) Other circumstances determined in rule by the Department of Health and
        Human Services pursuant to Title 22, section 7254, subsection 2; and
    Sec. 7. 32 MRSA §2600-C, sub-§2, ¶A, as enacted by PL 2015, c. 488, §17, is
amended by amending subparagraph (5) to read:
        (5) Other circumstances determined in rule by the Department of Health and
        Human Services pursuant to Title 22, section 7254, subsection 2; and
    Sec. 8. 32 MRSA §3300-F, sub-§2, ¶A, as enacted by PL 2015, c. 488, §20, is
amended by amending subparagraph (5) to read:
        (5) Other circumstances determined in rule by the Department of Health and
        Human Services pursuant to Title 22, section 7254, subsection 2; and
    Sec. 9. 32 MRSA §3657, sub-§2, ¶A, as enacted by PL 2015, c. 488, §23, is
amended by amending subparagraph (5) to read:
        (5) Other circumstances determined in rule by the Department of Health and
        Human Services pursuant to Title 22, section 7254, subsection 2; and
    Sec. 10. 32 MRSA §18308, sub-§2, ¶A, as enacted by PL 2015, c. 488, §32, is
amended by amending subparagraph (5) to read:
                                    Page 2 - 132LR0268(02)
(5) Other circumstances determined in rule by the Department of Health and
Human Services pursuant to Title 22, section 7254, subsection 2; and
                        Page 3 - 132LR0268(02)
